Anti-CD3 monoclonal antibody WT32

Drug Profile

Anti-CD3 monoclonal antibody WT32

Alternative Names: WT32

Latest Information Update: 11 Nov 2003

Price : $50

At a glance

  • Originator Nonindustrial source; Unknown
  • Developer Nonindustrial source
  • Class Monoclonal antibodies
  • Mechanism of Action CD3 antigen inhibitors; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Renal transplant rejection

Most Recent Events

  • 11 Nov 2003 Discontinued - Clinical-Phase-Unknown for Renal transplant rejection in Netherlands (unspecified route)
  • 23 Aug 1996 Investigation in Renal transplant rejection in Netherlands (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top